Simplex Trading’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $162K | Buy |
70,343
+27,534
| +64% | +$63.4K | ﹤0.01% | 1006 |
|
2025
Q1 | $334K | Buy |
+42,809
| New | +$334K | ﹤0.01% | 696 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 3211 |
|
2024
Q3 | – | Sell |
-5,786
| Closed | -$51K | – | 3080 |
|
2024
Q2 | $51K | Buy |
+5,786
| New | +$51K | ﹤0.01% | 1354 |
|
2024
Q1 | – | Sell |
-2,090
| Closed | -$23K | – | 3142 |
|
2023
Q4 | $23K | Sell |
2,090
-9,999
| -83% | -$110K | ﹤0.01% | 1613 |
|
2023
Q3 | $81K | Buy |
12,089
+9,299
| +333% | +$62.3K | ﹤0.01% | 1067 |
|
2023
Q2 | $25K | Buy |
2,790
+650
| +30% | +$5.82K | ﹤0.01% | 1460 |
|
2023
Q1 | $13K | Sell |
2,140
-667
| -24% | -$4.05K | ﹤0.01% | 1665 |
|
2022
Q4 | $17K | Buy |
2,807
+628
| +29% | +$3.8K | ﹤0.01% | 1655 |
|
2022
Q3 | $13K | Sell |
2,179
-4,113
| -65% | -$24.5K | ﹤0.01% | 1915 |
|
2022
Q2 | $55K | Sell |
6,292
-16,823
| -73% | -$147K | ﹤0.01% | 1373 |
|
2022
Q1 | $194K | Buy |
23,115
+20,805
| +901% | +$175K | ﹤0.01% | 1120 |
|
2021
Q4 | $23K | Sell |
2,310
-5,056
| -69% | -$50.3K | ﹤0.01% | 2131 |
|
2021
Q3 | $135K | Buy |
7,366
+600
| +9% | +$11K | ﹤0.01% | 1534 |
|
2021
Q2 | $118K | Buy |
+6,766
| New | +$118K | ﹤0.01% | 1628 |
|